Enavatuzumab
Product Specifications
CAS Number
1062149-33-0
Target
TNF
Related Pathways
Apoptosis
Purity
0.987
Bioactivity
Enavatuzumab (PDL192) is a humanized monoclonal antibody targeting the TWEAK receptor (TWEAKR), with anti-tumor activity. It induces tumor growth inhibition by recruiting and activating myeloid effectors to kill tumor cells. It is used in late-stage solid tumor research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1283047-01 0.02 mg (E-Coli)
Recombinant Idiomarina loihiensis Integration host factor subunit alpha (ihfA)
Ask
View Details MBS1283047-02 0.1 mg (E-Coli)
Recombinant Idiomarina loihiensis Integration host factor subunit alpha (ihfA)
Ask
View Details 
MBS1283047-03 0.02 mg (Yeast)
Recombinant Idiomarina loihiensis Integration host factor subunit alpha (ihfA)
Ask
View Details MBS1283047-04 0.1 mg (Yeast)
Recombinant Idiomarina loihiensis Integration host factor subunit alpha (ihfA)
Ask
View Details MBS1283047-05 0.02 mg (Baculovirus)
Recombinant Idiomarina loihiensis Integration host factor subunit alpha (ihfA)
Ask
View Details